Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Other Non Operating Income (2016 - 2026)

Wave Life Sciences filings provide 12 years of Other Non Operating Income readings, the most recent being -$80000.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 256.86% to -$80000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $396000.0, a 86.43% decrease, with the full-year FY2025 number at $527000.0, down 83.69% from a year prior.
  • Other Non Operating Income hit -$80000.0 in Q1 2026 for Wave Life Sciences, down from $234000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.5 million in Q4 2024 to a low of -$701000.0 in Q3 2022.
  • Median Other Non Operating Income over the past 5 years was $234000.0 (2025), compared with a mean of $327294.1.
  • Biggest five-year swings in Other Non Operating Income: surged 337.8% in 2024 and later plummeted 355.56% in 2025.
  • Wave Life Sciences' Other Non Operating Income stood at -$290000.0 in 2022, then surged by 300.69% to $582000.0 in 2023, then skyrocketed by 337.8% to $2.5 million in 2024, then plummeted by 90.82% to $234000.0 in 2025, then plummeted by 134.19% to -$80000.0 in 2026.
  • The last three reported values for Other Non Operating Income were -$80000.0 (Q1 2026), $234000.0 (Q4 2025), and $324000.0 (Q3 2025) per Business Quant data.